SCHEMBL30944265

SCHEMBL30944265

Cn1cc(-c2ccncc2CO)c(-c2ccc(F)cc2)n1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 12/20 0.65
CSNK1E P49674 9/20 0.65
MAPK14 Q16539 6/20 0.65
MAPK11 Q15759 5/20 0.65
MAPK13 O15264 3/20 0.65
MAPK12 P53778 3/20 0.65
MAP4K4 O95819 2/20 0.55
MAPK9 P45984 2/20 0.55
CSNK1A1 P48729 2/20 0.55
EGFR P00533 1/20 0.55
FRK P42685 1/20 0.55
NUAK1 O60285 1/20 0.47
ROCK2 O75116 1/20 0.47
LCK P06239 1/20 0.47
MAPK8 P45983 1/20 0.47
GSK3B P49841 1/20 0.47
MAP2K1 Q02750 1/20 0.47
MINK1 Q8N4C8 1/20 0.47
AURKB Q96GD4 1/20 0.47
KCNH2 Q12809 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9933667 0.85 CSNK1D (0.69) CSNK1DCSNK1EMAPK14MAPK11MAPK13
SCHEMBL5453393 0.82 CSNK1D (0.68) CSNK1DCSNK1EMAPK14MAPK11MAPK13
SCHEMBL5698604 0.80 CSNK1D (1.00) CSNK1DCSNK1EMAPK14MAPK11MAPK13
SCHEMBL5257540 0.80 CSNK1D (1.00) CSNK1DCSNK1EMAPK14MAPK11MAPK13
SCHEMBL9336643 0.79 RPS6KA3 (0.53) MAPK14MAPK11MAPK13MAPK12GSK3B
SCHEMBL30944203 0.78 CSNK1D (0.61) CSNK1DCSNK1EMAPK14MAPK11MAPK13
SCHEMBL24547924 0.73 CSNK1D (0.57) CSNK1DCSNK1EMAPK14MAPK11MAPK13
SCHEMBL3270981 0.72 CSNK1D (0.68) CSNK1DCSNK1EMAPK14MAPK11MAPK13
SCHEMBL21182078 0.71 CSNK1D (0.49) CSNK1DCSNK1EMAPK14MAPK11MAPK13
SCHEMBL9933712 0.71 CSNK1D (1.00) CSNK1DCSNK1EMAPK14MAPK11MAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4638448-A1 CONJUGATES COMPRISING ANTIFUNGALS AND CASEIN KINASE (CK1) INHIBITORS AND METHODS OF USE THEREOF Bright Angel Therapeutics Inc. (CA) 2025-10-29 EP disclosed
WO-2024130408-A1 CONJUGATES COMPRISING ANTIFUNGALS AND CASEIN KINASE (CK1) INHIBITORS AND METHODS OF USE THEREOF BRIGHT ANGEL THERAPEUTICS INC. (CA) 2024-06-27 WO disclosed